Navigation Links
WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
Date:2/19/2013

iling as well as single nucleotide polymorphism (SNP) genotyping.

For additional information, please see http://www.wafergen.com

About QIAGEN

QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of December 31, 2012, QIAGEN employed approximately 4,000 people in over 35 locations worldwide. QIAGEN KK is a wholly owned subsidiary of QIAGEN NV of about 100 employees who market QIAGEN's entire product portfolio across all Japanese customer classes. Further information can be found at http://www.qiagen.com  

Forward Looking Statements

This press release contains certain "forward-looking statements."  Such statements include statements relating to the expected benefits to the Company of
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
2. WaferGen to Present Corporate Overview at Oppenheimer Healthcare Conference
3. WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012
4. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
5. WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
6. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
7. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
8. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
9. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
10. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
11. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... A team of Spanish scientists from a variety of ... the peridunal lagoons in the Doana National Park. Results ... regressing, largely due to the extraction of underground water ... effects of the ecosystem itself are further aggravating the ...
... Fibrocell Science, Inc. (OTCBB: FCSC) announced today that the ... Gene Therapies Advisory Committee reviewed azfibrocel-T, an autologous cell ... severe nasolabial fold wrinkles in adults. The committee voted ... on azfibrocel-T demonstrated efficacy, and 6 yes to 8 ...
... ( www.booshoot.com ) today announced that its ... of Martha Stewart "Dreamers Into Doers" program - an ... passions into a successful for-profit or non-profit career. ... in the for-profit category for her innovative and groundbreaking ...
Cached Biology Technology:Huelva is swallowing up coastal lagoons in Doñana 2Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles 2Booshoot Founder & CEO Jackie Heinricher Honored as Visionary Entrepreneur by Martha Stewart 2
(Date:4/23/2014)... most in their mid-thirties and forties, face a ... within two decades. "Mutant" protein clusters, long blamed ... been the primary focus of therapies in development ... from Prof. Gerardo Lederkremer and Dr. Julia Leitman ... and Immunology, in collaboration with Prof. Ulrich Hartl ...
(Date:4/23/2014)... NY. (Apr. 23 2014) A team ... stem cells (hNSCs) into the brains of nonhuman ... 22 and 24 months found that the hNSCs ... did not cause tumors. , The study will ... Cell Transplantation but is currently freely available ...
(Date:4/23/2014)... group decision increases with the abundance of brains involved ... variety of factors as often happens in life ... groups actually tend to make more accurate decisions while ... pieces of information. , The findings present a significant ... the "wisdom of crowds," wherein individual observations even ...
Breaking Biology News(10 mins):On the defensive 2On the defensive 3Study finds long-term survival of human neural stem cells transplanted into primate brain 2Too many chefs: Smaller groups exhibit more accurate decision-making 2Too many chefs: Smaller groups exhibit more accurate decision-making 3
... new study describes how bacteria use a previously unknown means ... have modified a common "housekeeping" enzyme in a way that ... The study appears in the Proceedings of the ... in chemical warfare with one another, and many antibiotics used ...
... A 12-week treatment of the fermented soy germ-based ... LDL cholesterol and improved vascular stiffness, all factors that ... first-of-its-kind peer-reviewed study reported in a poster at the ... study is the first to provide evidence that a ...
... by a University of Cincinnati undergraduate student and two team ... found to work in continuously recording the habits of snakes. ... Archival Tags (LATs) on snakes, since the LAT devices were ... to LATs, ability to measure temperature and pressure measuring ...
Cached Biology News:Team discovers how bacteria resist a 'Trojan horse' antibiotic 2Soy-based S-equol supplement reduces metabolic syndrome risk factors 2Soy-based S-equol supplement reduces metabolic syndrome risk factors 3UC research: Tracking Lake Erie water snake in fight against invasive fish 2UC research: Tracking Lake Erie water snake in fight against invasive fish 3